<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>NASDAQ Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0000854222</cik>
        <entityName>Endo Pharmaceuticals Solutions Inc.</entityName>
        <fileNumber>000-18728</fileNumber>
        <address>
            <street1>33 Hayden Avenue</street1>
            <street2></street2>
            <city>Lexington</city>
            <stateOrCountryCode>MA</stateOrCountryCode>
            <stateOrCountry>MASSACHUSETTS</stateOrCountry>
            <zipCode>02421</zipCode>
        </address>
        <telephoneNumber>781-861-8444</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Tara Petta</signatureName>
        <signatureTitle>Director</signatureTitle>
        <signatureDate>2009-03-23</signatureDate>
    </signatureData>
</notificationOfRemoval>
